BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $754,519 | -34.2% | 16,561 | +24.1% | 0.06% | -8.7% |
| Q4 2021 | $1,146,000 | -38.3% | 13,346 | -42.2% | 0.07% | -33.7% |
| Q3 2021 | $1,856,000 | -11.1% | 23,078 | -11.0% | 0.10% | -7.1% |
| Q2 2021 | $2,087,000 | -18.1% | 25,926 | -11.0% | 0.11% | +273.3% |
| Q3 2019 | $2,548,000 | +24.8% | 29,130 | +16.9% | 0.03% | -25.0% |
| Q2 2019 | $2,042,000 | +295.7% | 24,928 | +293.0% | 0.04% | +300.0% |
| Q1 2019 | $516,000 | -7.5% | 6,343 | -25.2% | 0.01% | -16.7% |
| Q4 2018 | $558,000 | +173.5% | 8,481 | +219.8% | 0.01% | +200.0% |
| Q3 2018 | $204,000 | -81.9% | 2,652 | -82.6% | 0.00% | -86.2% |
| Q2 2018 | $1,125,000 | +120.6% | 15,233 | +94.1% | 0.03% | +107.1% |
| Q1 2018 | $510,000 | -9.6% | 7,849 | -10.0% | 0.01% | -12.5% |
| Q4 2017 | $564,000 | -82.4% | 8,722 | -82.9% | 0.02% | -84.3% |
| Q3 2017 | $3,199,000 | +14.8% | 50,976 | +10.8% | 0.10% | +24.4% |
| Q2 2017 | $2,786,000 | -86.4% | 46,021 | -88.4% | 0.08% | -85.3% |
| Q1 2017 | $20,489,000 | +9.2% | 395,085 | -6.6% | 0.56% | -10.0% |
| Q4 2016 | $18,764,000 | -44.6% | 423,194 | -40.5% | 0.62% | +6.4% |
| Q3 2016 | $33,849,000 | +3963.5% | 711,120 | +3759.1% | 0.58% | +4057.1% |
| Q2 2016 | $833,000 | -95.5% | 18,427 | -95.9% | 0.01% | -93.1% |
| Q1 2016 | $18,659,000 | -50.4% | 454,203 | -54.0% | 0.20% | -39.7% |
| Q4 2015 | $37,654,000 | +21.4% | 987,011 | +122.6% | 0.34% | +17.5% |
| Q2 2015 | $31,013,000 | -51.1% | 443,493 | -52.1% | 0.28% | -43.6% |
| Q1 2015 | $63,361,000 | +173.8% | 924,981 | +192.9% | 0.50% | +76.0% |
| Q4 2014 | $23,145,000 | +545.4% | 315,795 | +532.1% | 0.29% | +1003.8% |
| Q3 2014 | $3,586,000 | -62.8% | 49,963 | -62.5% | 0.03% | -60.6% |
| Q2 2014 | $9,642,000 | – | 133,358 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |